Phasic and Sustained Fear are Pharmacologically Dissociable in Rats (original) (raw)
Arluison M, Brochier G, Vankova M, Leviel V, Villalobos J, Tramu G (1994). Demonstration of peptidergic afferents to the bed nucleus of the stria terminalis using local injections of colchicine. A combined immunohistochemical and retrograde tracing study. Brain Res Bull34: 319–337. ArticleCAS Google Scholar
Baas JM, Grillon C, Bocker KB, Brack AA, Morgan III CA, Kenemans JL et al (2002). Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology (Berl)161: 233–247. ArticleCAS Google Scholar
Bitsios P, Philpott A, Langley RW, Bradshaw CM, Szabadi E (1999). Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man. J Psychopharmacol13: 226–234. ArticleCAS Google Scholar
Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE (2004). The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry55: 1171–1178. ArticleCAS Google Scholar
Cassell MD, Gray TS, Kiss JZ (1986). Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J Comp Neurol246: 478–499. ArticleCAS Google Scholar
Chalmers DT, Lovenberg TW, De Souza EB (1995). Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci15: 6340–6350. ArticleCAS Google Scholar
Christopoulos G, Paxinos G, Huang XF, Beaumont K, Toga AW, Sexton PM (1995). Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can J Physiol Pharmacol73: 1037–1041. ArticleCAS Google Scholar
Commissaris RL, Davis M (1982). Opposite effects of N,_N_-dimethyltryptamine (DMT) and 5-methoxy-n,_n_-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action. Neurosci Biobehav Rev6: 515–520. ArticleCAS Google Scholar
Davis M (1979). Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology (Berl)62: 1–7. ArticleCAS Google Scholar
Davis M (1986). Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm. Behav Neurosci100: 814–824. ArticleCAS Google Scholar
Davis M (2006). Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol61: 741–756. Article Google Scholar
Davis M, Astrachan DI, Gendelman PM, Gendelman DS (1980a). 5-Methoxy-N,_N_-dimethyltryptamine: spinal cord and brainstem mediation of excitatory effects on acoustic startle. Psychopharmacology (Berl)70: 123–130. ArticleCAS Google Scholar
Davis M, Cassella JV, Kehne JH (1988). Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Psychopharmacology (Berl)94: 14–20. ArticleCAS Google Scholar
Davis M, Strachan DI, Kass E (1980b). Excitatory and inhibitory effects of serotonin on sensorimotor reactivity measured with acoustic startle. Science209: 521–23. ArticleCAS Google Scholar
Davis M, Walker DL, Miles L, Grillon C (2010). Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology35: 105–135. Article Google Scholar
Freedman LJ, Shi C (2001). Monoaminergic innervation of the macaque extended amygdala. Neuroscience104: 1067–1084. ArticleCAS Google Scholar
Gewirtz JC, McNish KA, Davis M (1998). Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle. Prog Neuropsychopharmacol Biol Psychiatry22: 625–648. ArticleCAS Google Scholar
Goa KL, Ward A (1986). Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs32: 114–129. ArticleCAS Google Scholar
Goodman WK (2004). Selecting pharmacotherapy for generalized anxiety disorder. J Clin Psychiatry65 (Suppl 13): 8–13. CASPubMed Google Scholar
Graham SJ, Scaife JC, Langley RW, Bradshaw CM, Szabadi E, Xi L et al (2005). Effects of lorazepam on fear-potentiated startle responses in man. J Psychopharmacol19: 249–258. ArticleCAS Google Scholar
Gray TS, Magnuson DJ (1992). Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides13: 451–460. ArticleCAS Google Scholar
Grillon C, Baas JM (2002). Comments on the use of the startle reflex in psychopharmacological challenges: impact of baseline startle on measurement of fear-potentiated startle. Psychopharmacology (Berl)164: 236–238. ArticleCAS Google Scholar
Grillon C, Baas JM, Pine DS, Lissek S, Lawley M, Ellis V et al (2006). The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry60: 760–766. ArticleCAS Google Scholar
Grillon C, Chavis C, Covington MF, Pine DS (2009a). Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study. Neuropsychopharmacology34: 964–971. ArticleCAS Google Scholar
Grillon C, Lissek S, Rabin S, McDowell D, Dvir S, Pine DS (2008). Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. Am J Psychiatry165: 898–904. Article Google Scholar
Grillon C, Pine DS, Lissek S, Rabin S, Bonne O, Vythilingam M (2009b). Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biol Psychiatry66: 47–53. Article Google Scholar
Guscott MR, Cook GP, Bristow LJ (2000). Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/gamma-aminobutyric acid-A receptor agonists. Behav Pharmacol11: 495–504. ArticleCAS Google Scholar
Hammack SE, Guo JD, Hazra R, Dabrowska J, Myers KM, Rainnie DG (2009). The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety. Prog Neuropsychopharmacol Biol Psychiatry33: 1309–1320. ArticleCAS Google Scholar
Hammack SE, Richey KJ, Watkins LR, Maier SF (2004). Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behav Neurosci118: 443–448. Article Google Scholar
Hitchcock JM, Davis M (1991). Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav Neurosci105: 826–842. ArticleCAS Google Scholar
Jacobson AF, Dominguez RA, Goldstein BJ, Steinbook RM (1985). Comparison of buspirone and diazepam in generalized anxiety disorder. Pharmacotherapy5: 290–296. ArticleCAS Google Scholar
Ju G, Swanson LW, Simerly RB (1989). Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture. J Comp Neurol280: 603–621. ArticleCAS Google Scholar
Kehne JH, Cassella JV, Davis M (1988). Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacology (Berl)94: 8–13. ArticleCAS Google Scholar
Klumpers F, Raemaekers MA, Ruigrok AN, Hermans EJ, Kenemans JL, Baas JM (2010). Prefrontal mechanisms of fear reduction after threat offset. Biol Psychiatry68: 1031–1038. Article Google Scholar
Kruger L, Mantyh PW, Sternini C, Brecha NC, Mantyh CR (1988). Calcitonin gene-related peptide (CGRP) in the rat central nervous system: patterns of immunoreactivity and receptor binding sites. Brain Res463: 223–244. ArticleCAS Google Scholar
Lee Y, Davis M (1997). Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci17: 6434–6446. ArticleCAS Google Scholar
Li XB, Inoue T, Hashimoto S, Koyama T (2001). Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur J Pharmacol425: 43–50. ArticleCAS Google Scholar
Liang KC, Melia KR, Campeau S, Falls WA, Miserendino MJ, Davis M (1992). Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex. J Neurosci12: 2313–2320. ArticleCAS Google Scholar
Mansbach RS, Geyer MA (1988). Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands. Eur J Pharmacol156: 375–383. ArticleCAS Google Scholar
McNish KA, Gewirtz JC, Davis M (1997). Evidence of contextual fear after lesions of the hippocampus: a disruption of freezing but not fear-potentiated startle. J Neurosci17: 9353–9360. ArticleCAS Google Scholar
Melia KR, Davis M (1991). Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepam. Physiol Behav49: 603–611. ArticleCAS Google Scholar
Meloni EG, Davis M (1999). Muscimol in the deep layers of the superior colliculus/mesencephalic reticular formation blocks expression but not acquisition of fear-potentiated startle in rats. Behav Neurosci113: 1152–1160. ArticleCAS Google Scholar
Oler JA, Fox AS, Shelton SE, Christian BT, Murali D, Oakes TR et al (2009). Serotonin transporter availability in the amygdala and bed nucleus of the stria terminalis predicts anxious temperament and brain glucose metabolic activity. J Neurosci29: 9961–9966. ArticleCAS Google Scholar
Patrick CJ, Berthot BD, Moore JD (1996). Diazepam blocks fear-potentiated startle in humans. J Abnorm Psychol105: 89–96. ArticleCAS Google Scholar
Phelix CF, Liposits Z, Paull WK (1992). Serotonin-CRF interaction in the bed nucleus of the stria terminalis: a light microscopic double-label immunocytochemical analysis. Brain Res Bull28: 943–948. ArticleCAS Google Scholar
Phelps EA, O’Connor KJ, Gatenby JC, Gore JC, Grillon C, Davis M (2001). Activation of the left amygdala to a cognitive representation of fear. Nat Neurosci4: 437–441. ArticleCAS Google Scholar
Quinn JJ, Oommen SS, Morrison GE, Fanselow MS (2002). Post-training excitotoxic lesions of the dorsal hippocampus attenuate forward trace, backward trace, and delay fear conditioning in a temporally specific manner. Hippocampus12: 495–504. Article Google Scholar
Quirk GJ, Repa C, LeDoux JE (1995). Fear conditioning enhances short-latency auditory responses of lateral amygdala neurons: parallel recordings in the freely behaving rat. Neuron15: 1029–1039. ArticleCAS Google Scholar
Riba J, Rodriguez-Fornells A, Urbano G, Morte A, Antonijoan R, Barbanoj MJ (2001). Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose–response study. Psychopharmacology (Berl)157: 358–367. ArticleCAS Google Scholar
Roberts GW, Woodhams PL, Polak JM, Crow TJ (1982). Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex. Neuroscience7: 99–131. ArticleCAS Google Scholar
Rosen JB, Hitchcock JM, Sananes CB, Miserendino MJ, Davis M (1991). A direct projection from the central nucleus of the amygdala to the acoustic startle pathway: anterograde and retrograde tracing studies. Behav Neurosci105: 817–825. ArticleCAS Google Scholar
Santos JM, Martinez RC, Brandao ML (2006). Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning. Eur J Pharmacol542: 121–128. ArticleCAS Google Scholar
Scaife JC, Langley RW, Bradshaw CM, Szabadi E (2005). Diazepam suppresses the acquisition but not the expression of ‘fear-potentiation’ of the acoustic startle response in man. J Psychopharmacol19: 347–356. ArticleCAS Google Scholar
Shimada S, Inagaki S, Kubota Y, Ogawa N, Shibasaki T, Takagi H (1989). Coexistence of peptides (corticotropin releasing factor/neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat. Neuroscience30: 377–383. ArticleCAS Google Scholar
Sink KS, Walker DL, Yang Y, Davis M (2011). Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. J Neurosci31: 1802–1810. ArticleCAS Google Scholar
Skofitsch G, Jacobowitz DM (1985). Autoradiographic distribution of 125I calcitonin gene-related peptide binding sites in the rat central nervous system. Peptides6: 975–986. ArticleCAS Google Scholar
Smith HR, Daunais JB, Nader MA, Porrino LJ (1999). Distribution of [3H]citalopram binding sites in the nonhuman primate brain. Ann NY Acad Sci877: 700–702. ArticleCAS Google Scholar
Somerville LH, Whalen PJ, Kelley WM (2010). Human bed nucleus of the stria terminalis indexes hypervigilant threat monitoring. Biol Psychiatry68: 416–424. Article Google Scholar
Sullivan GM, Apergis J, Bush DE, Johnson LR, Hou M, Ledoux JE (2004). Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience128: 7–14. ArticleCAS Google Scholar
Waddell J, Morris RW, Bouton ME (2006). Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci120: 324–336. Article Google Scholar
Walker D, Yang Y, Ratti E, Corsi M, Trist D, Davis M (2009a). Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses. Neuropsychopharmacology34: 1533–1542. ArticleCAS Google Scholar
Walker DL, Davis M (1997a). Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol Psychiatry42: 461–471. ArticleCAS Google Scholar
Walker DL, Davis M (1997b). Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned vs unconditioned fear. J Neurosci17: 9375–9383. ArticleCAS Google Scholar
Walker DL, Davis M (2002a). Light-enhanced startle: further pharmacological and behavioral characterization. Psychopharmacology (Berl)159: 304–310. ArticleCAS Google Scholar
Walker DL, Davis M (2002b). Quantifying fear potentiated startle using absolute vs proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology (Berl)164: 318–328. ArticleCAS Google Scholar
Walker DL, Miles LA, Davis M (2009b). Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like vs phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry33: 1291–1308. ArticleCAS Google Scholar
Walter A, Mai JK, Lanta L, Gorcs T (1991). Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J Chem Neuroanat4: 281–298. ArticleCAS Google Scholar
Winslow JT, Noble PL, Davis M (2007). Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone. Biol Psychiatry61: 389–395. ArticleCAS Google Scholar
Woodhams PL, Roberts GW, Polak JM, Crow TJ (1983). Distribution of neuropeptides in the limbic system of the rat: the bed nucleus of the stria terminalis, septum and preoptic area. Neuroscience8: 677–703. ArticleCAS Google Scholar
Zhao Z, Davis M (2004). Fear-potentiated startle in rats is mediated by neurons in the deep layers of the superior colliculus/deep mesencephalic nucleus of the rostral midbrain through the glutamate non-NMDA receptors. J Neurosci24: 10326–10334. ArticleCAS Google Scholar